Lamotrigine Eg (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels in neurons, which stabilises the neuronal membrane and reduces the release of excitatory neurotransmitters such as glutamate. This action lowers neuronal hyper‑excitability, decreasing seizure activity and influencing mood pathways.

The specific dose of Lamotrigine Eg is determined by the prescribing clinician based on the patient’s age, weight, indication, and response to therapy. Dosage adjustments are made gradually to minimise the risk of skin reactions.

The safety of lamotrigine during pregnancy and lactation is not fully established. Healthcare providers weigh potential benefits against possible risks, and women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their physician.

To request Lamotrigine Eg, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Compared with older anticonvulsants such as carbamazepine or phenytoin, lamotrigine has a broader spectrum for partial seizures and a favourable mood‑stabilising profile for bipolar disorder. However, it requires careful titration to avoid rash, and its interactions differ, especially with enzyme‑inducing drugs.

Lamotrigine Eg should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Lamotrigine Eg is taken orally, usually as a tablet, with or without food. The prescribing clinician will provide a dosing schedule that often starts with a low dose and increases gradually to reach the therapeutic target while monitoring for side effects.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood disorders like agranulocytosis, hepatic failure, and the emergence of suicidal thoughts. Immediate medical attention is required if any of these symptoms appear.

Lamotrigine Eg should be avoided in individuals with a known hypersensitivity to lamotrigine or any of its components, and in patients taking strong enzyme inducers without appropriate dose adjustment. Clinicians should also assess suitability in patients with severe liver impairment or a history of serious rash.